QA: ALPINE IMMUNE SCIENCES INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001626199_2023_ALPINE_IMMUNE_SCIENCES_INC.pdf

Logs

Graph

Absolute values for 0001626199, ALPINE IMMUNE SCIENCES INC.

  xvar xval
0 AssetsCurrent 240,993,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,584,000
3 remainder_Assets 44,109,000
4 LiabilitiesCurrent 57,996,000
5 LiabilitiesNoncurrent 49,270,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,968,000
9 ResearchAndDevelopmentExpense 70,243,000
10 remainder_Expenses 2,806,000
11 remainder_Revenues 30,064,000
12 remainder_NetIncome 3,191,000
13 remainder_ComprehensiveNetIncome -848,000
  yvar yval
0 Assets 286,686,000
1 Liabilities 107,266,000
2 Expenses 91,017,000
3 Revenues 30,064,000
4 StockholdersEquity 179,420,000
5 NetIncome -57,762,000
6 ComprehensiveNetIncome -58,186,000
7 BaseVar 259,536,000
8 EconomicCapitalRatio 1.27

Edgar->Model Mapping

Feature Distribution

Change over Time